Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD340 (HER-2) expression on human breast cancer cell lines. Cells from either the MCF7 (ATCC HTB-22; Left Panel) or SK-BR-3 (ATCC HTB-30D-2; Right Panel) human breast adenocarcinoma cell line were stained with either BD Horizon BV421™ Mouse IgG1, κ Isotype Control (Cat. No. 562438; dashed line histograms) or BD Horizon BV421 Mouse Anti-Human CD340 (HER-2) antibody (Cat. No. 566458/566459; solid line histograms) at 0.5 μg/test. The histograms showing CD340 (HER-2) expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of CD340 (HER-2) expression on human breast cancer cell lines. Cells from either the MCF7 (ATCC HTB-22; Left Panel) or SK-BR-3 (ATCC HTB-30D-2; Right Panel) human breast adenocarcinoma cell line were stained with either BD Horizon BV421™ Mouse IgG1, κ Isotype Control (Cat. No. 562438; dashed line histograms) or BD Horizon BV421 Mouse Anti-Human CD340 (HER-2) antibody (Cat. No. 566458/566459; solid line histograms) at 0.5 μg/test. The histograms showing CD340 (HER-2) expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of CD340 (HER-2) expression on human breast cancer cell lines. Cells from either the MCF7 (ATCC HTB-22; Left Panel) or SK-BR-3 (ATCC HTB-30D-2; Right Panel) human breast adenocarcinoma cell line were stained with either BD Horizon BV421™ Mouse IgG1, κ Isotype Control (Cat. No. 562438; dashed line histograms) or BD Horizon BV421 Mouse Anti-Human CD340 (HER-2) antibody (Cat. No. 566458/566459; solid line histograms) at 0.5 μg/test. The histograms showing CD340 (HER-2) expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of CD340 (HER-2) expression on human breast cancer cell lines. Cells from either the MCF7 (ATCC HTB-22; Left Panel) or SK-BR-3 (ATCC HTB-30D-2; Right Panel) human breast adenocarcinoma cell line were stained with either BD Horizon BV421™ Mouse IgG1, κ Isotype Control (Cat. No. 562438; dashed line histograms) or BD Horizon BV421 Mouse Anti-Human CD340 (HER-2) antibody (Cat. No. 566458/566459; solid line histograms) at 0.5 μg/test. The histograms showing CD340 (HER-2) expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of CD340 (HER-2) expression on human breast cancer cell lines. Cells from either the MCF7 (ATCC HTB-22; Left Panel) or SK-BR-3 (ATCC HTB-30D-2; Right Panel) human breast adenocarcinoma cell line were stained with either BD Horizon BV421™ Mouse IgG1, κ Isotype Control (Cat. No. 562438; dashed line histograms) or BD Horizon BV421 Mouse Anti-Human CD340 (HER-2) antibody (Cat. No. 566458/566459; solid line histograms) at 0.5 μg/test. The histograms showing CD340 (HER-2) expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of CD340 (HER-2) expression on human breast cancer cell lines. Cells from either the MCF7 (ATCC HTB-22; Left Panel) or SK-BR-3 (ATCC HTB-30D-2; Right Panel) human breast adenocarcinoma cell line were stained with either BD Horizon BV421™ Mouse IgG1, κ Isotype Control (Cat. No. 562438; dashed line histograms) or BD Horizon BV421 Mouse Anti-Human CD340 (HER-2) antibody (Cat. No. 566458/566459; solid line histograms) at 0.5 μg/test. The histograms showing CD340 (HER-2) expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System. Data shown on this Technical Data Sheet are not lot specific.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes are used in the same experiment. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349).
The 24D2 monoclonal antibody specifically recognizes CD340 which is also known as Human epidermal growth factor receptor 2 (HER-2 or HER2), Neu (neuro/glioblastoma derived oncogene homolog), or Metastatic lymph node gene 19 protein (MLN19). CD340 (HER-2) is a ~185 kDa type I transmembrane glycoprotein that is encoded by ERBB2 (erb-b2 receptor tyrosine kinase 2) and belongs to the ERBB family of receptor tyrosine kinases that includes EGFR, HER3, and HER4. Although CD340 (HER-2) has no identified direct-binding ligand, it can form heterodimers with other ligand-bound ERBB family members. CD340 (HER-2) helps activate intracellular signaling pathways including mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI-3K) through its cytoplasmic tyrosine kinase-containing region. CD340 (HER-2) is expressed by bone marrow mesenchymal stem cells. It is overexpressed and plays a significant role in the development of multiple human cancers including some leukemias, neuroblastomas, and carcinomas of the breast, ovary, cervix, colon, and lung.
The antibody was conjugated to BD Horizon BV421 which is part of the BD Horizon Brilliant™ Violet family of dyes. With an Ex Max of 407-nm and Em Max at 421-nm, BD Horizon BV421 can be excited by the violet laser and detected in the standard Pacific Blue™ filter set (eg, 450/50-nm filter). BD Horizon BV421 conjugates are very bright, often exhibiting a 10 fold improvement in brightness compared to Pacific Blue conjugates.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.